Vir Biotechnology, Inc. (VIR)
VIR price $10.59 -0.15 -1.44%
- Ticker
- VIR
- Price
- $10.59
- Change
- -0.15 -1.44%
- Market cap
- $1.79B
- P/E
- -5.81
- Sector
- Healthcare
- Industry
- Biotechnology
- Stocklytics score
- 64
Vir Biotechnology, Inc. operates as an immunology company with commercialized products, dedicated to devising therapeutic solutions for the treatment and prevention of significant infectious diseases. Its pipeline features several key candidates: Sotrovimab (branded as Xevudy, or VIR-7832), a neutralizing monoclonal antibody for both treating and preventing SARS-CoV-2 infection; VIR-2218 and VIR-3434, aimed at…